Skip to main content
Log in

ICER reports on peanut allergy, RA and spinal muscular atrophy

  • News item
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Institute for Clinical and Economic Review. ICER Releases Draft Evidence Report on Treatments for Peanut Allergy. Internet Document : 9 Apr 2019. Available from: URL: https://icer-review.org/announcements/peanut-draft-evidence-report/

  2. Institute for Clinical and Economic Review. ICER Posts Draft Scoping Document for the Assessment of Treatments for Rheumatoid Arthritis Internet Document : 11 Apr 2019. Available from: URL: https://icer-review.org/announcements/ra_update_draft_scope/

  3. ICER. ICER Issues Final Report on Spinraza and Zolgensma, Provides Policy Recommendations Related to Pricing and Coverage of Treatments for Spinal Muscular Atrophy. Internet Document : 3 Apr 2019. Available from: URL: https://icer-review.org/announcements/icer-issues-final-report-on-sma/

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICER reports on peanut allergy, RA and spinal muscular atrophy. PharmacoEcon Outcomes News 826, 2 (2019). https://doi.org/10.1007/s40274-019-5804-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-019-5804-y

Navigation